CURE vs. XTJL
Compare and contrast key facts about Direxion Daily Healthcare Bull 3x Shares (CURE) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL).
CURE and XTJL are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. CURE is a passively managed fund by Direxion that tracks the performance of the Health Care Select Sector Index (300%). It was launched on Jun 15, 2011. XTJL is an actively managed fund by Innovator. It was launched on Jul 1, 2021.
Performance
CURE vs. XTJL - Performance Comparison
Loading graphics...
CURE vs. XTJL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | -15.60% | 22.55% | -8.47% | -9.40% | -20.51% | 35.13% |
XTJL Innovator U.S. Equity Accelerated Plus ETF - July | -0.71% | 15.42% | 14.43% | 25.72% | -15.66% | 7.28% |
Returns By Period
In the year-to-date period, CURE achieves a -15.60% return, which is significantly lower than XTJL's -0.71% return.
CURE
- 1D
- 2.50%
- 1M
- -19.24%
- YTD
- -15.60%
- 6M
- 3.42%
- 1Y
- -5.59%
- 3Y*
- 0.66%
- 5Y*
- 3.67%
- 10Y*
- 13.60%
XTJL
- 1D
- 0.66%
- 1M
- -1.72%
- YTD
- -0.71%
- 6M
- 1.81%
- 1Y
- 16.00%
- 3Y*
- 14.59%
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
CURE vs. XTJL - Expense Ratio Comparison
CURE has a 1.08% expense ratio, which is higher than XTJL's 0.79% expense ratio.
Return for Risk
CURE vs. XTJL — Risk / Return Rank
CURE
XTJL
CURE vs. XTJL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CURE | XTJL | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.11 | 0.88 | -0.99 |
Sortino ratioReturn per unit of downside risk | 0.22 | 1.41 | -1.20 |
Omega ratioGain probability vs. loss probability | 1.03 | 1.28 | -0.25 |
Calmar ratioReturn relative to maximum drawdown | -0.32 | 1.18 | -1.50 |
Martin ratioReturn relative to average drawdown | -0.59 | 7.45 | -8.04 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| CURE | XTJL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.11 | 0.88 | -0.99 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.08 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.28 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.47 | 0.57 | -0.10 |
Correlation
The correlation between CURE and XTJL is 0.58, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
CURE vs. XTJL - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.26%, while XTJL has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.26% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
XTJL Innovator U.S. Equity Accelerated Plus ETF - July | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
CURE vs. XTJL - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, which is greater than XTJL's maximum drawdown of -23.24%. Use the drawdown chart below to compare losses from any high point for CURE and XTJL.
Loading graphics...
Drawdown Indicators
| CURE | XTJL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -23.24% | -45.95% |
Max Drawdown (1Y)Largest decline over 1 year | -33.92% | -13.81% | -20.11% |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | — | — |
Current DrawdownCurrent decline from peak | -33.01% | -2.12% | -30.89% |
Average DrawdownAverage peak-to-trough decline | -17.95% | -4.18% | -13.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.24% | 2.19% | +16.05% |
Volatility
CURE vs. XTJL - Volatility Comparison
Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 14.17% compared to Innovator U.S. Equity Accelerated Plus ETF - July (XTJL) at 4.50%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than XTJL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| CURE | XTJL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.17% | 4.50% | +9.67% |
Volatility (6M)Calculated over the trailing 6-month period | 30.26% | 6.30% | +23.96% |
Volatility (1Y)Calculated over the trailing 1-year period | 52.84% | 18.18% | +34.66% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.35% | 15.46% | +27.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.47% | 15.46% | +34.01% |